In vivo administration of 15-deoxyspergulin inhibits antigen-presenting cell stimulation of T cells and NF-κB activation
- 30 September 2002
- journal article
- Published by Elsevier in International Immunopharmacology
- Vol. 2 (10) , 1451-1464
- https://doi.org/10.1016/s1567-5769(02)00090-5
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Identification of a Binding Site on Hsc70 for the Immunosuppressant 15-DeoxyspergualinBiochemical and Biophysical Research Communications, 1998
- 15‐Deoxyspergualin: A Newly Developed Immunosuppressive Agent and Its Mechanism of Action and Clinical Effect: A ReviewArtificial Organs, 1996
- The yeast nucleoporin Nsp1 binds nuclear localization sequences in vitroBiochemistry and Cell Biology, 1996
- Intranuclear binding on nucleoplasminJournal of Cellular Biochemistry, 1995
- Structure, Regulation and Function of NF-kappaBAnnual Review of Cell Biology, 1994
- PREVENTION OF THE HUMORAL RESPONSE INDUCED BY AN ANTI-CD3 MONOCLONAL ANTIBODY BY DEOXYSPERGUALIN IN A MURINE MODEL1Transplantation, 1994
- Increased Graft Survival by Utilization of 15-Deoxyspergualin in a Canine Pancreatic Allotransplantation ModelEuropean Surgical Research, 1994
- 15‐Deoxyspergualin: A Novel Immunosuppressive Drug with Clinical PotentialaAnnals of the New York Academy of Sciences, 1993
- Regulation of HIV Production by Blood Mononuclear Cells from HIV-Infected Donors: II. HIV-1 Production Depends on T Cell-Monocyte InteractionAIDS Research and Human Retroviruses, 1993
- Superantigens interact with MHC class II molecules outside of the antigen grooveCell, 1990